甘草次酸及其衍生物在神经退行性疾病中的防治作用研究进展
CSTR:
作者:
作者单位:

1. 山东中医药大学中医学院,济南 250355;2. 山东中医药大学中医药创新研究院,济南 250355

作者简介:

通讯作者:

中图分类号:

基金项目:


Advancements in research on the preventive and curative roles of glycyrrhetinic acid and its derivatives in neurodegenerative disease
Author:
Affiliation:

1. College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine,Jinan 250355, China; 2. Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    随着全球人口老龄化加剧,神经退行性疾病发病率逐年上升,严重影响老年患者的生活质量,给社会带来沉重负担。 甘草次酸是中药甘草的主要活性成分之一,具有抑制神经炎症、保护神经元等作用,对于甘草次酸及其衍生物在神经退行性疾病中的作用机制研究日益增多。 本研究综述了甘草次酸及其衍生物在阿尔茨海默病、帕金森病、肌萎缩性脊髓侧索硬化症、多发性硬化和小脑萎缩的作用及其机制的研究,并对其未来在神经退行性疾病中的应用进行讨论与展望。

    Abstract:

    The annual incidence of neurodegenerative disease has been increasing with the aging of the global population, seriously affecting the quality of life of elderly patients and imposing a heavy burden on society. Glycyrrhetinic acid, which inhibits neuroinflammation and protects neurons, is one of the main active ingredients of the traditional Chinese medicine Glycyrrhiza glabra. Increasing numbers of studies are focusing on the mechanism of action of glycyrrhetinic acid and its derivatives in neurodegenerative disease. This review summarizes studies on the effects and mechanisms of action of glycyrrhetinic acid and its derivatives in Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis, and cerebellar atrophy. Additionally, the future applications of glycyrrhetinic acid and its derivatives in neurodegenerative disorders are discussed.

    参考文献
    相似文献
    引证文献
引用本文

刘翼骁,韩欣园,肖依彤,于昕卓,叶田园.甘草次酸及其衍生物在神经退行性疾病中的防治作用研究进展[J].中国实验动物学报,2024,32(7):923~932.

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-12-22
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-08-26
  • 出版日期:
文章二维码
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭